ROC analysis revealed that the proportion of CD4+ and its subpopulation could distinguish GIR from PIR, while PIR patients are associated with higher incidence of EBV reactivation and PTLD, suggested that early CD4+ reconstitution may predict EBV infection post-transplantation. The gene discussed is CD4; the disease is Epstein-Barr virus infection.